Gilead to buy Kite Pharma in $11 billion deal: WSJ

(Reuters) - Gilead Sciences Inc has agreed to buy Kite Pharma Inc for about $11 billion in an all-cash deal, the Wall Street Journal reported on Monday, citing people familiar with the matter.